These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 23090048

  • 1. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.
    Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, Bauer JJ.
    J Clin Gastroenterol; 2013 Jul; 47(6):491-5. PubMed ID: 23090048
    [Abstract] [Full Text] [Related]

  • 2. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
    White EC, Melmed GY, Vasiliauskas E, Dubinsky M, Ippoliti A, McGovern D, Targan S, Fleshner P.
    Dis Colon Rectum; 2012 May; 55(5):563-8. PubMed ID: 22513435
    [Abstract] [Full Text] [Related]

  • 3. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

  • 4. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
    El-Hussuna A, Andersen J, Bisgaard T, Jess P, Henriksen M, Oehlenschlager J, Thorlacius-Ussing O, Olaison G.
    Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications.
    Mascarenhas C, Nunoo R, Asgeirsson T, Rivera R, Kim D, Hoedema R, Dujovny N, Luchtefeld M, Davis AT, Figg R.
    Am J Surg; 2012 Mar; 203(3):375-8; discussion 378. PubMed ID: 22364904
    [Abstract] [Full Text] [Related]

  • 6. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?
    Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD.
    Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease.
    Kanazawa A, Yamana T, Okamoto K, Sahara R.
    Dis Colon Rectum; 2012 Sep; 55(9):957-62. PubMed ID: 22874602
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
    Syed A, Cross RK, Flasar MH.
    Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
    [Abstract] [Full Text] [Related]

  • 9. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
    Myrelid P, Marti-Gallostra M, Ashraf S, Sunde ML, Tholin M, Oresland T, Lovegrove RE, Tøttrup A, Kjaer DW, George BD.
    Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
    [Abstract] [Full Text] [Related]

  • 10. Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease.
    Ahmed Ali U, Martin ST, Rao AD, Kiran RP.
    Dis Colon Rectum; 2014 May; 57(5):663-74. PubMed ID: 24819109
    [Abstract] [Full Text] [Related]

  • 11. The effect of immune therapy on surgical site infection following Crohn's Disease resection.
    Serradori T, Germain A, Scherrer ML, Ayav C, Perez M, Romain B, Palot JP, Rohr S, Peyrin-Biroulet L, Bresler L.
    Br J Surg; 2013 Jul; 100(8):1089-93. PubMed ID: 23649458
    [Abstract] [Full Text] [Related]

  • 12. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
    Shental O, Tulchinsky H, Greenberg R, Klausner JM, Avital S.
    Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
    [Abstract] [Full Text] [Related]

  • 13. The impact of obesity on outcomes following major surgery for Crohn's disease: an American College of Surgeons National Surgical Quality Improvement Program assessment.
    Causey MW, Johnson EK, Miller S, Martin M, Maykel J, Steele SR.
    Dis Colon Rectum; 2011 Dec; 54(12):1488-95. PubMed ID: 22067176
    [Abstract] [Full Text] [Related]

  • 14. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy.
    Amiot A, Gornet JM, Baudry C, Munoz-Bongrand N, Auger M, Simon M, Allez M, Cattan P, Sarfati E, Lémann M.
    Dig Liver Dis; 2011 Sep; 43(9):698-702. PubMed ID: 21474398
    [Abstract] [Full Text] [Related]

  • 15. Impact of perioperative immunosuppressive medication on surgical outcome in Crohn's Disease (CD).
    Eisner F, Küper MA, Ziegler F, Zieker D, Königsrainer A, Glatzle J.
    Z Gastroenterol; 2014 May; 52(5):436-40. PubMed ID: 24824908
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Similar outcomes of surgical and medical treatment of intra-abdominal abscesses in patients with Crohn's disease.
    Nguyen DL, Sandborn WJ, Loftus EV, Larson DW, Fletcher JG, Becker B, Mandrekar J, Harmsen WS, Bruining DH.
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):400-4. PubMed ID: 22155562
    [Abstract] [Full Text] [Related]

  • 20. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB, Decanini A, Mellgren A, Lowry AC, Goldberg SM, Madoff RD, Spencer MP.
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.